Method for constructing engineering bacteria for producing rhamnolipid and application of engineering bacteria

The construction of high-yield rhamnolipid-producing engineered strains through normal pressure room temperature plasma mutagenesis technology, solving the problems of low yield and high cost in the existing technology, and achieving efficient and stable rhamnolipid-producing, suitable for biosurfactivity industrial production of agents.

CN118931894APending Publication Date: 2024-11-12WANHUA CHEM GRP CO LTD

Patent Information

Application Number
CN202411419518.9
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-10-12
Publication Date
2024-11-12

AI Technical Summary

Technical Problem

The existing rhamnolipid production process has problems of low yield and high cost, which limits its industrial application.

Method used

The wild-type rhamnolipid production strain was mutagenerated by normal pressure room temperature plasma mutagenesis technology, and engineered strains with high yield of rhamnolipid were screened out, and specific fermentation media were designed to improve production efficiency and stability.

Benefits of technology

The engineering strain with stable and high yield of rhamnolipids was successfully constructed, which increased yield, reduced production costs, and achieved rapid growth and efficient production of bacteria, which was suitable for industrial applications.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118931894A_ABST
    Figure CN118931894A_ABST
Patent Text Reader

Abstract

The invention relates to a method for constructing engineering bacteria for producing rhamnolipid and application of the engineering bacteria. The method comprises the following steps: (1) selecting a wild rhamnolipid production strain, culturing, and collecting the strain; (2) performing mutagenesis treatment on the strains collected in the step (1) by using normal-pressure and room-temperature plasma mutagenesis equipment to obtain a mutagenic strain library; and (3) screening the mutagenized strain library, and selecting the strain with high yield of rhamnolipid. According to the invention, a normal-pressure room-temperature plasma mutagenesis system is used for mutagenizing the rhamnolipid production strain to construct the engineering bacterium for producing the rhamnolipid at high yield, and the application of the engineering bacterium in the production of the biosurfactant is provided, so that the yield of the rhamnolipid is improved, and a new way is provided for the production of the biosurfactant.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of genetic engineering and relates to a method for constructing an engineering bacterium producing rhamnolipid and an application thereof. Background Art

[0002] Rhamnolipid is a biological surfactant with biological metabolic properties produced by Pseudomonas or Burkholderia. It has multiple physiological activities, including antioxidant, anti-inflammatory and anti-tumor effects. It is an anionic surfactant with oil-water amphiphilicity. It can significantly reduce the surface tension of water and has multiple functions such as emulsification, demulsification, defoaming, washing, dispersion and flocculation, antistatic and lubrication. It is widely used in environmental protection, agriculture, food, medicine and other fields.

[0003] At present, the production of rhamnolipids is mainly achieved through fermentation engineering, and there are many production processes and methods. A common production method is to use Pseudomonas or Burkholderia for fermentation. These microorganisms can naturally produce rhamnolipids. For example, CN102796781A discloses a method for fermenting and separating rhamnolipids with Pseudomonas aeruginosa, which includes the following steps: 1) using the slant inoculation method to transfer the Pseudomonas aeruginosa strain into a shake bottle for expansion culture to obtain a Pseudomonas aeruginosa seed liquid; 2) first add the fermentation medium to the fermentation tank for sterilization, and then connect the Pseudomonas aeruginosa seed liquid to the fermentation tank for fermentation according to the inoculation amount of 8%~12%. Before inoculating the seed liquid, add 1~5‰ of bubodiol to the culture medium; the Pseudomonas aeruginosa seed liquid is fermented for 120 hours to obtain a paste fermentation liquid; 3) using a separation device to extract and distill the paste fermentation liquid twice to obtain a paste rhamnolipid with a purity of 80%~90%. CN117126904A discloses a method for cyclic continuous fermentation of rhamnolipid, comprising fermenting and culturing rhamnolipid-producing microorganisms in a fermentation medium, controlling the carbon-nitrogen ratio during the fermentation process, and taking out part of the fermentation liquid under certain conditions, etc., wherein the synthetic yield of rhamnolipid reaches more than 86 g / L, and the substrate conversion rate reaches 68%. However, the current traditional rhamnolipid production process has problems such as low yield and high cost, which limits its industrial application.

[0004] Developing high-yield strains is one of the effective ways to achieve efficient production of bio-fermentation products. Common methods for developing high-yield strains include genetic engineering or artificial mutagenesis. At present, the demand for rhamnolipids is growing, and it is of great significance to develop an engineered bacterium that produces high-yield rhamnolipids. Summary of the invention

[0005] In view of the deficiencies of the prior art and actual needs, the present invention provides a method for constructing an engineered bacterium producing rhamnolipid and its application, and constructs an engineered bacterium with high rhamnolipid production through atmospheric pressure and room temperature plasma mutagenesis to increase the rhamnolipid production, thereby providing a new approach for the production of biosurfactants.

[0006] The present invention adopts the following technical solutions:

[0007] In a first aspect, the present invention provides a method for constructing an engineered bacterium producing rhamnolipid, the method comprising the following steps:

[0008] (1) Selecting wild-type rhamnolipid-producing strains for cultivation and collecting the strains;

[0009] (2) using an atmospheric pressure and room temperature plasma (ARTP) mutagenesis device to mutagenize the strains collected in step (1) to obtain a mutagenized strain library; the mutagenesis treatment conditions are: using helium as gas, a ventilation flow rate of 10-16 L / min, an action distance of 2-4 mm, an action power of 120-160 W, and an action time of 30-120 s;

[0010] (3) Screen the mutagenic strain library and select strains with high rhamnolipid production.

[0011] In the present invention, a normal pressure and room temperature plasma mutagenesis method is designed for rhamnolipid production strains, and combined with molecular biology technology, an engineering bacterium capable of stably and highly producing rhamnolipids can be constructed.

[0012] Optionally, the above-listed 10-16 L / min, 2-4 mm, 120-160 W and 30-120 s indicate that any value can be taken within the corresponding range, such as 10-16 L / min includes but is not limited to 11, 12, 13, 14 or 15 L / min, etc.; 120-160 W includes but is not limited to 121, 125, 130, 135, 140, 145, 150, 155, 156, 158 or 159 W, etc., 30-120 s includes but is not limited to 35, 40, 50, 60, 70, 75, 80, 85, 90, 95, 100, 105, 110 or 115 s, etc., and they are not listed one by one.

[0013] Preferably, the wild-type rhamnolipid producing strain comprises Pseudomonas and / or Burkholderia.

[0014] Preferably, the Pseudomonas includes at least one of Pseudomonas aeruginosa, Pseudomonas putica or Pseudomonas fluorescens.

[0015] Preferably, the Pseudomonas aeruginosa is purchased from the China Industrial Microorganism Culture Collection Center, number: CICC10351; Pseudomonas fluorescens is purchased from the China Industrial Microorganism Culture Collection Center, number: CICC 23246; Pseudomonas putida is purchased from the China Industrial Microorganism Culture Collection Center, number: CICC 21906.

[0016] Preferably, the culture medium in step (1) contains, by mass percentage, 1% to 5% glycerol, 0.5% to 1.2% yeast powder, 1.0% to 3.2% peptone, 0.5% to 2% NaNO3, 0.2% to 0.8% KH2PO4, 0.5% to 1.0% Na2HPO4·12H2O, 0.2% to 0.9% MgSO4·7H2O, 1.2% to 1.8% CaCl2·2H2O, 0.2% to 0.9% FeSO4 and 0.6% to 1.8% CoCl2, with the remainder being water.

[0017] Preferably, in step (2), the strain collected in step (1) is diluted with physiological saline to an OD 660 After the pH value is between 0.6 and 0.9, mutagenesis treatment is carried out.

[0018] Preferably, the screening method comprises a blue gel plate screening method.

[0019] Preferably, the blue gel plate screening method specifically comprises inoculating the strain into a culture medium containing cetyltrimethylammonium bromide (CTAB) and methylene blue for culturing.

[0020] Preferably, the method for constructing an engineered bacterium producing rhamnolipids further comprises the step of testing the stability of the strain with high rhamnolipid production, specifically comprising fermenting and culturing the selected strain with high rhamnolipid production and detecting the rhamnolipid production.

[0021] Preferably, the fermentation culture temperature is 28-38° C., the initial pH of the fermentation is 6.2-7.2, the initial rotation speed is 150-200 rpm, the initial ventilation volume is 0.2-0.5 vvm, and the dissolved oxygen is controlled to be above 20%.

[0022] Preferably, the method for culturing the seed solution for fermentation culture comprises: inoculating the strain into a seed culture medium, and culturing at 28-38° C. and 150-200 rpm for 8-12 h to obtain the seed solution.

[0023] Preferably, the seed liquid is inoculated into the initial fermentation medium at an inoculation rate of 3% to 6%.

[0024] In a second aspect, the present invention provides an engineered bacterium producing rhamnolipid, which is obtained by the method for constructing an engineered bacterium producing rhamnolipid.

[0025] The invention successfully constructs an engineered strain that stably produces high-yield rhamnolipids without degeneration based on a designed mutagenesis method.

[0026] In a third aspect, the present invention provides the use of the rhamnolipid-producing engineered bacteria in the production of rhamnolipid.

[0027] The high-rhamnolipid-producing engineering strain obtained by the invention has high yield, good stability, is easy to industrialize, and can be effectively applied to the production of rhamnolipid.

[0028] In a fourth aspect, the present invention provides a method for producing rhamnolipid, the method comprising:

[0029] The rhamnolipid-producing engineered bacteria are cultured and the product is purified to obtain rhamnolipid.

[0030] It is understood that the cultivation methods for producing rhamnolipids by strains commonly used in the art and the corresponding purification methods are applicable to the present invention.

[0031] Preferably, the culture medium for the fermentation culture contains, by mass percentage, 1% to 5% glycerol, 0.5% to 1.2% yeast powder, 1.0% to 3.2% peptone, 0.5% to 2% NaNO3, 0.2% to 0.8% KH2PO4, 0.5% to 1.0% Na2HPO4·12H2O, 0.2% to 0.9% MgSO4·7H2O, 1.2% to 1.8% CaCl2·2H2O, 0.2% to 0.9% FeSO4 and 0.6% to 1.8% CoCl2, with the remainder being water.

[0032] The specific fermentation medium designed in the present invention is beneficial to reducing production costs, and can promote rapid growth of bacteria and improve production efficiency.

[0033] Compared with the prior art, the present invention has the following beneficial effects:

[0034] The invention utilizes a normal pressure and room temperature plasma mutagenesis system to induce mutagenesis on a rhamnolipid production strain, constructs an engineered bacterium with high rhamnolipid production, obtains a strain with high rhamnolipid production, performs stability testing on a strain library after mutagenesis screening, obtains a strain capable of stably producing high rhamnolipid without degeneration, further develops its application in the production of biosurfactants, designs a fermentation medium, is beneficial to reducing production costs, promotes rapid bacterial growth, and realizes efficient production of rhamnolipid. BRIEF DESCRIPTION OF THE DRAWINGS

[0035] Figure 1 This is the initial screening result of the blue gel plate screening method. DETAILED DESCRIPTION

[0036] The technical solution of the present invention is further described below in conjunction with the accompanying drawings and through specific implementation methods. However, the following embodiments are merely examples of the present invention and do not represent or limit the protection scope of the present invention.

[0037] If no specific techniques or conditions are specified in the examples, the techniques or conditions described in the literature in the field or the product instructions are used. If no manufacturer is specified for the reagents or instruments used, they are all conventional products that can be purchased through regular channels.

[0038] Example 1

[0039] 1. Weigh the culture medium. The culture medium formula is: mass percentage formula: glycerol 1%, yeast powder 0.5%, peptone 1.0%, NaNO3 0.5%, KH2PO4 0.2%, Na2HPO4·12H2O 0.5%, MgSO4·7H2O 0.2%, CaCl2·2H2O1.2%, FeSO4 0.2%, CoCl2 0.6%, and the balance is water.

[0040] 2. Sterilize the culture medium at 115°C for 20 minutes and cool to room temperature before use.

[0041] 3. Take Pseudomonas aeruginosa (Pseudomonas aeruginosa, purchased from China Industrial Microbiological Culture Collection Center, No.: CICC 10351), inoculate it into the culture medium, and perform fermentation amplification culture.

[0042] 4. The inoculum size is 3%, culture is carried out at 35°C and 180 rpm for 12 h, and the OD is greater than 10.

[0043] 5. When the OD of the microorganism is greater than 10, the fermentation can be stopped and mutation breeding can be carried out.

[0044] 6. Dilute the cultured microorganisms with 0.9% saline to an OD 660 =0.7.

[0045] 7. Take 12 μL of bacterial solution and spread it evenly on a sterile small iron sheet. After air drying, put it into the breeding machine for mutagenesis.

[0046] 8. According to the operating procedures of the ARTP biological mutation breeding machine, the breeding conditions are helium as the gas, ventilation flow rate of 16 L / min, action distance of 3 mm, and action power of 120 W.

[0047] 9. Set the processing time to 60 s.

[0048] 10. The blue gel plate screening method was used for preliminary screening. The hexadecyl trimethylammonium bromide (CTAB) and methylene blue in the plate reacted with the anionic surfactant rhamnolipid to form a blue halo. The ratio of the blue halo diameter to the colony diameter was measured to preliminarily measure the level of rhamnolipid production. The results were as follows: Figure 1 shown.

[0049] 11. Conduct stability study on the screened strain library to determine whether the yield of continuous rhamnolipid production decreases.

[0050] 12. In the stability study, the screened strain library was inoculated into the seed culture medium and cultured at 37°C and 180 rpm to obtain the seed solution.

[0051] 13. Inoculate the seed liquid into the initial fermentation medium at a 5% inoculum rate. The fermentation temperature is 38°C, the initial pH of the fermentation is 7.2, the initial speed is 180 rpm, the initial ventilation is 0.3 vvm, and the speed and ventilation are increased according to the dissolved oxygen to control the dissolved oxygen above 20%.

[0052] 14. During the rhamnolipid fermentation process, the rhamnolipid concentration should be tested every hour. The tank can be stopped when the rhamnolipid concentration does not increase for two consecutive hours.

[0053] Rhamnolipid concentration detection methods include:

[0054] First, a rhamnolipid standard curve was prepared. The rhamnolipid standard was diluted to 0.1, 0.2, 0.5, and 1 g / L, and its absorbance at a wavelength of 620 nm was measured respectively. The concentration was used as the horizontal axis and the absorbance value as the vertical axis to fit the standard curve. 2 >0.99, then measure the sample: centrifuge the fermentation broth at 10℃ and 4000 rpm for 20 min to precipitate the bacteria, take the supernatant after centrifugation and dilute it a certain multiple; then take 1 mL of the dilution and add it to a test tube, put the test tube into ice water, slowly add 4 mL of 0.2% anthrone reagent along the wall of the test tube, and shake it continuously to mix evenly; then immerse the test tube in a boiling water bath and heat it for 15 min, take it out and immediately cool it with cold water to terminate the reaction, and place it at room temperature for 20 min; finally, use an ultraviolet spectrophotometer to measure the absorbance of a series of rhamnose solutions at a wavelength of 620 nm, use the uninoculated fermentation medium as a blank control, and measure the absorbance of the diluted supernatant; finally, substitute the measured absorbance into the rhamnolipid standard curve equation to obtain the rhamnolipid content.

[0055] Calculation of rhamnolipid purity: rhamnolipid concentration × volume / total weight of precipitate.

[0056] 15. Obtain a genetically engineered Pseudomonas aeruginosa strain with high rhamnolipid production.

[0057] 16. After 46 h of growth, the rhamnolipid fermentation concentration of the genetically engineered bacteria was 96 g / L, and the production efficiency was 2.09 g / L / h.

[0058] Example 2

[0059] Fermentation was carried out according to the steps basically the same as those in Example 1, except that in step 1, a culture medium was prepared, and its composition was as follows: the mass percentage formula was 5% glycerol, 0.9% yeast powder, 2.5% peptone, 0.9% NaNO3, 0.6% KH2PO4, 0.7% Na2HPO4·12H2O, 0.6% MgSO4·7H2O, 1.1% CaCl2·2H2O, 0.7% FeSO4, 1.2% CoCl2, and the balance was water.

[0060] Example 3

[0061] Fermentation was carried out according to the steps basically the same as those in Example 1, except that in step 1, a culture medium was prepared, and the composition was as follows: the culture medium formula was: the mass percentage formula was 3% glycerol, 1.2% yeast powder, 3.2% peptone, 2% NaNO3, 0.8% KH2PO4, 1.0% Na2HPO4·12H2O, 0.9% MgSO4·7H2O, 1.8% CaCl2·2H2O, 0.9% FeSO4, 1.8% CoCl2, and the balance was water.

[0062] Example 4

[0063] Fermentation was performed by referring to the same steps as those in Example 1, except that in step 9, the processing time was set to 30 seconds.

[0064] Example 5

[0065] Fermentation was performed by referring to the same steps as those in Example 1, except that in step 9, the processing time was set to 120 seconds.

[0066] Example 6

[0067] Fermentation was performed by referring to the same steps as those in Example 1, except that in step 9, the processing time was set to 90 seconds.

[0068] Example 7

[0069] Fermentation was carried out according to the same steps as in Example 1, except that in step 8, the aeration flow rate was set to 10 L / min.

[0070] Example 8

[0071] Fermentation was carried out according to the same steps as in Example 1, except that in step 8, the action distance was set to 4 mm.

[0072] Example 9

[0073] Fermentation was carried out according to the same steps as in Example 1, except that in step 8, the action distance was set to 2 mm.

[0074] Example 10

[0075] Fermentation was carried out according to the same steps as in Example 1, except that in step 8, the operating power was set to 160 W.

[0076] Embodiment 11

[0077] The fermentation was carried out by referring to the steps basically the same as those in Example 1, except that in step 3, Pseudomonas fluorescens (purchased from China Industrial Microbiological Culture Collection Center, No.: CICC23246) was inoculated into the culture medium for fermentation and amplification culture.

[0078] Example 12

[0079] The fermentation was carried out by referring to the steps basically the same as those in Example 1, except that in step 3, Pseudomonas putica (purchased from China Industrial Microbiological Culture Collection Center, No.: CICC21906) was inoculated into the culture medium for fermentation and amplification culture.

[0080] Comparative Example 1

[0081] The fermentation was carried out according to the same steps as those in Example 1, except that in step 3, Yarrowia lipolytica (purchased from China Industrial Microbiological Culture Collection Center, No.: CICC 32291) was inoculated into the culture medium for fermentation and amplification culture.

[0082] Comparative Example 2

[0083] The fermentation was carried out according to the same steps as those in Example 1, except that in step 3, Saccharomyces cerevisiae (purchased from China Industrial Microbiological Culture Collection Center, No.: CICC 1388) was inoculated into the culture medium for fermentation and amplification culture.

[0084] Comparative Example 3

[0085] Fermentation was performed by referring to the same steps as in Example 1, except that Pseudomonas aeruginosa (purchased from China Industrial Microbiological Culture Collection Center, number: CICC 10351) was not induced to undergo mutagenesis, and the other culture conditions were the same.

[0086] Comparative Example 4

[0087] The fermentation was carried out according to the same steps as in Example 1, except that Pseudomonas fluorescens (Pseudomonas fluorescens purchased from China Industrial Microbiological Culture Collection Center, No.: CICC 23246) was not induced to undergo mutagenesis, and the other culture conditions were the same.

[0088] Comparative Example 5

[0089] The fermentation was carried out according to the same steps as in Example 1, except that Pseudomonas putida (Pseudomonas putica purchased from China Industrial Microbiological Culture Collection Center, No.: CICC 21906) was not induced to undergo mutagenesis, and the other culture conditions were the same.

[0090] The rhamnolipid production capacity of the strains of each embodiment and comparative example was compared. The results are shown in Table 1. When Example 1 was cultured to the 45th-46th hour, the rhamnolipid concentration was detected for two consecutive hours and no longer increased, and the fermentation was stopped. The detected rhamnolipid concentration was 96 g / L, and the yield was (96 g / L) / (46 h)=2.09 g / L / h. The ratio of halo to colony diameter was 2.3:1. Compared with the comparative example 3 (diameter ratio of 1.01:1) without mutagenesis, the rhamnolipid yield was relatively high, which proved that the mutagenesis method was feasible and the mutagenesis results were good. Example 2-3 appropriately adjusted the concentration range of the culture medium, and the results were not much different from Example 1.

[0091] Examples 4-6 control different plasma mutagenesis treatment times, wherein in Example 5, a large number of bacteria died during the mutagenesis process, the effect was poor, and the production capacity of the obtained strain was low. The production capacity of the strain obtained by mutagenesis in Example 4 was also low, indicating that the present invention can further improve the strain production capacity by controlling the specific mutagenesis treatment time.

[0092] Examples 11-12 are mutagenesis treatments of different wild strains producing rhamnolipids, which demonstrate the applicability of the method of the present invention. Due to the differences in the strains themselves, the experimental results are different from those of Example 1.

[0093] Comparative Example 1-2 is a mutagenesis treatment of a wild strain that cannot produce rhamnolipid, and the results are very poor, which proves the specificity of the method of the present invention.

[0094] Comparative Examples 3-5 are strains that were not induced to undergo mutation, and are used as references to demonstrate the significance of the method of the present invention.

[0095] Table 1

[0096]

[0097] In summary, the present invention uses a normal pressure room temperature plasma mutagenesis system to induce mutagenesis of a rhamnolipid production strain, constructs an engineered bacterium with high rhamnolipid production, and provides an application of the engineered bacterium in the production of biosurfactants, which significantly increases the yield of rhamnolipid and provides a new approach for the production of biosurfactants.

[0098] The above description is only a preferred embodiment of the present invention, but the protection scope of the present invention is not limited thereto. Those skilled in the art should understand that within the technical scope disclosed by the present invention, any changes or substitutions that can be easily made fall within the protection scope of the present invention.

Claims

1. A method for constructing an engineered bacterium producing rhamnolipid, characterized in that: The method comprises the following steps: (1) Selecting wild-type rhamnolipid-producing strains for cultivation and collecting the strains; (2) using a normal pressure room temperature plasma mutagenesis device to perform mutagenesis on the strains collected in step (1) to obtain a mutagenized strain library; the mutagenesis treatment conditions are: using helium as gas, a ventilation flow rate of 10-16 L / min, an action distance of 2-4 mm, an action power of 120-160 W, and an action time of 30-120 s; (3) Screen the mutagenic strain library and select strains with high rhamnolipid production.

2. The method for constructing an engineering bacterium producing rhamnolipid according to claim 1, characterized in that: The wild-type rhamnolipid producing strain includes Pseudomonas and / or Burkholderia; The Pseudomonas includes at least one of Pseudomonas aeruginosa, Pseudomonas putida or Pseudomonas fluorescens.

3. The method for constructing an engineering bacterium producing rhamnolipid according to claim 1, characterized in that: The culture medium in step (1) contains, by mass percentage, 1% to 5% glycerol, 0.5% to 1.2% yeast powder, 1.0% to 3.2% peptone, 0.5% to 2% NaNO3, 0.2% to 0.8% KH2PO4, 0.5% to 1.0% Na2HPO4·12H2O, 0.2% to 0.9% MgSO4·7H2O, 1.2% to 1.8% CaCl2·2H2O, 0.2% to 0.9% FeSO4 and 0.6% to 1.8% CoCl2, with the remainder being water.

4. The method for constructing an engineering bacterium producing rhamnolipid according to claim 1, characterized in that: In step (2), the strain collected in step (1) is diluted with saline to an OD of 660 After the pH value is between 0.6 and 0.9, mutagenesis treatment is carried out.

5. The method for constructing an engineering bacterium producing rhamnolipid according to claim 1, characterized in that: The screening method includes a blue gel plate screening method.

6. The method for constructing an engineering bacterium producing rhamnolipid according to claim 1, characterized in that: The method for constructing an engineered bacterium producing rhamnolipid also includes a step of testing the stability of the strain with high rhamnolipid production, specifically including fermenting and culturing the selected strain with high rhamnolipid production and detecting the rhamnolipid production.

7. The method for constructing an engineered bacterium producing rhamnolipid according to claim 6, characterized in that: The fermentation culture temperature is 28-38° C., the initial fermentation pH is 6.2-7.2, the initial rotation speed is 150-200 rpm, the initial ventilation volume is 0.2-0.5 vvm, and the dissolved oxygen is controlled to be above 20%.

8. An engineered bacterium producing rhamnolipid, characterized in that: The engineered bacteria are obtained by the method for constructing an engineered bacterium producing rhamnolipid according to claim 1.

9. Use of the rhamnolipid-producing engineered bacteria according to claim 8 in the production of rhamnolipid.

10. A method for producing rhamnolipid, characterized in that: The method comprises: Cultivate the rhamnolipid-producing engineered bacteria according to claim 8, purify the product, and obtain rhamnolipid.

Citation Information

Patent Citations

  • Bacillus subtilis strain and applications thereof

    CN103865855A

  • Preparation method of plasma-induced rhamnolipid emulsified asphalt

    CN107189460A

  • Method for circularly and continuously fermenting rhamnolipid

    CN117126904A

Cited By

  • Rhamnolipid fermentation and separation method

    CN119799822A